Skip to main content
Equibles
GENB logo

GENB · Generate Biomedicines, Inc. · Held by Funds

Track GENB — free

Use GENB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GENB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.06 +0.49 (+3.90%) At close · Nov 6
Russell 2000 member Rebalance outlook locked
Going-concern doubt — cleared Aug 6, 2026

The latest filing states the doubt was alleviated.

“As of December 31, 2025, the Company had concluded that there was substantial doubt about its ability to continue as a going concern. Upon closing of the IPO and receipt of the associated cash proceeds, the Company has alleviated the substantial doubt that previously existed, and based on the Company’s current capital resources, which consists of its cash, cash equivalents and marketable securities on hand at June 30, 2026, it expects to have sufficient cash to fund our current operating plan into the first half of 2028.”
View the 10-Q filed Aug 6, 2026
Market Cap
$1.68B
Shares
128.35M
Volume · Nov 6 632.2K Avg daily vol (3M) 1.2M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of GENB by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 1.76% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.21% 265,100
Index ETFs 1.56% 1,997,042
Active ETFs 0.39% 503,595
Active funds 5.36% 6,881,250
Unclassified 0.21% 266,290
All registered funds 7.72% 9,913,277
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding GENB

108 fund positions
Fund Balance Value % of Fund Open
SMALLCAP World Fund Inc 3,752,630 $63,306,868 0.07%
Fidelity Growth Company Fund 2,186,392 $33,386,206 0.03%
ARK Genomic Revolution ETF 1,237,891 $17,330,474 1.11%
VANGUARD TOTAL STOCK MARKET INDEX FUND 816,876 $13,780,698 0.00%
Fidelity Growth Company K6 Fund 695,890 $10,626,240 0.04%
iShares Russell 2000 ETF 617,886 $10,423,737 0.01%
JPMorgan Small Cap Growth Fund 580,246 $9,788,750 0.38%
Fidelity Series Growth Company Fund 555,621 $8,484,333 0.03%
ARK Venture Fund 409,871 $5,738,194 0.48%
T. Rowe Price Health Sciences Fund, Inc. 314,964 $5,313,443 0.04%
VANGUARD EXTENDED MARKET INDEX FUND 296,479 $5,001,601 0.01%
Eaton Vance Worldwide Health Sciences Fund 308,946 $4,717,605 0.59%
Fidelity Small Cap Index Fund 267,202 $3,740,828 0.01%
JPMorgan Small Cap Blend Fund 184,432 $3,111,368 0.18%
iShares Russell 2000 Growth ETF 157,860 $2,663,098 0.02%
American Funds U.S. Small & Mid Cap Equity Fund 174,326 $2,661,958 0.26%
ALPS Medical Breakthroughs ETF 157,939 $2,411,729 1.00%
VANGUARD RUSSELL 2000 INDEX FUND 139,555 $2,131,005 0.01%
Fidelity Extended Market Index Fund 127,711 $1,950,147 0.00%
Schwab U.S. Small-Cap ETF 119,988 $1,832,217 0.01%
SMALLCAP World Fund 103,973 $1,754,025 0.07%
Fidelity Nasdaq Composite Index Fund 78,426 $1,197,565 0.00%
Multi-Manager Small Cap Equity Strategies Fund 74,822 $1,142,532 0.10%
iShares Russell 2000 Value ETF 66,087 $1,114,888 0.01%
JPMorgan U.S. Small Company Fund 59,616 $1,005,722 0.09%
Fidelity Total Market Index Fund 54,909 $838,460 0.00%
Schwab Small-Cap Index Fund 59,231 $829,234 0.01%
Master Small Cap Index Series 45,633 $769,829 0.01%
Fidelity Nasdaq Composite Index ETF 42,094 $642,775 0.01%
Fidelity Series Total Market Index Fund 39,607 $604,799 0.00%
Nuveen Small Cap Blend Index Fund 32,382 $453,348 0.01%
U.S. Small and Mid Cap Equity Fund 26,842 $452,825 0.41%
EQ/2000 Managed Volatility Portfolio 26,125 $440,729 0.01%
Schwab Total Stock Market Index Fund 25,592 $358,288 0.00%
Virtus Biotech Clinical Trials Etf 25,106 $351,484 0.76%
Select Biotechnology Portfolio 21,800 $332,886 0.01%
Health Sciences Trust 19,277 $325,203 0.13%
T. Rowe Price Health Sciences Portfolio 19,115 $322,470 0.04%
LVIP State Street Small-Cap Index Fund 17,700 $298,599 0.01%
Schwab U.S. Broad Market ETF 18,814 $287,290 0.00%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND 18,253 $278,723 0.02%
Blackstone Alternative Multi-Strategy Fund 16,438 $277,309 0.01%
Fidelity Small Cap Growth Index Fund 15,724 $265,264 0.02%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND 14,889 $251,177 0.00%
EQ/T.Rowe Price Health Sciences Portfolio 13,453 $226,952 0.13%
Tema Healthcare AI ETF 14,823 $226,347 2.95%
LVIP JPMorgan Small Cap Core Fund 13,304 $224,438 0.09%
Small Cap Index Fund 12,605 $212,646 0.01%
Fidelity Small Cap Value Index Fund 10,571 $178,333 0.01%
Small Cap Index Fund 10,671 $162,946 0.01%
Showing 1–50 of 108 positions
Key facts CIK 2100782 CUSIP 370920100 13F (30d) 35 filings 35 filers Visit website Investor relations